Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic Cancer and Its Microenvironment—Recent Advances and Current Controversies
Kinga B. Stopa, Agnieszka A. Kusiak, Mateusz D. Szopa, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3218-3218
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Improved unsupervised physics‐informed deep learning for intravoxel incoherent motion modeling and evaluation in pancreatic cancer patients
Misha Kaandorp, Sebastiano Barbieri, Remy Klaassen, et al.
Magnetic Resonance in Medicine (2021) Vol. 86, Iss. 4, pp. 2250-2265
Open Access | Times Cited: 73
Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes
Katherine Richards, Weikun Xiao, Reginald Hill
Cancers (2022) Vol. 14, Iss. 11, pp. 2812-2812
Open Access | Times Cited: 43
Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia
Pavan Kumar Chintamaneni, Sai Kiran S. S. Pindiprolu, Swati Swagatika Swain, et al.
Cancer Letters (2024) Vol. 588, pp. 216782-216782
Open Access | Times Cited: 10
Small Extracellular Vesicles Promote Stiffness-mediated Metastasis
Alexandra Sneider, Ying Liu, Bartholomew Starich, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 5, pp. 1240-1252
Open Access | Times Cited: 7
pH-Channeling in Cancer: How pH-Dependence of Cation Channels Shapes Cancer Pathophysiology
Zoltán Pethő, Karolina Najder, Tiago M. A. Carvalho, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2484-2484
Open Access | Times Cited: 42
When healing turns into killing – the pathophysiology of pancreatic and hepatic fibrosis
Paweł E. Ferdek, Daria Krzysztofik, Kinga B. Stopa, et al.
The Journal of Physiology (2022) Vol. 600, Iss. 11, pp. 2579-2612
Open Access | Times Cited: 23
Pancreatic Ductal Adenocarcinoma (PDAC): Clinical Progress in the Last Five Years
Osama Mosalem, Ahmed Abdelhakeem, Nayef Hikmat Abdel-Razeq, et al.
Expert Opinion on Investigational Drugs (2025), pp. 1-12
Closed Access
Toyaburgine, a Synthetic N-Biphenyl-Dihydroisoquinoline Inspired by Related N,C-Coupled Naphthylisoquinoline Alkaloids, with High In Vivo Efficacy in Preclinical Pancreatic Cancer Models
Suresh Awale, Juthamart Maneenet, Nguyễn Duy Phan, et al.
ACS Chemical Biology (2025)
Closed Access
Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition
Robert Wilson, Rami Archid, Marc A. Reymond
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4158-4158
Open Access | Times Cited: 32
Mechanically stressed cancer microenvironment: Role in pancreatic cancer progression
Matthew Hadden, Anubhav Mittal, Jaswinder S. Samra, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188418-188418
Closed Access | Times Cited: 29
Advances in bioengineering pancreatic tumor-stroma physiomimetic Biomodels
Maria V. Monteiro, Luís P. Ferreira, Marta Rocha, et al.
Biomaterials (2022) Vol. 287, pp. 121653-121653
Closed Access | Times Cited: 17
Optimizing pseudo‐spiral sampling for abdominal DCE MRI using a digital anthropomorphic phantom
Nienke Wassenaar, Oliver J. Gurney‐Champion, Anne‐Sophie van Schelt, et al.
Magnetic Resonance in Medicine (2024) Vol. 92, Iss. 5, pp. 2051-2064
Open Access | Times Cited: 3
CD36 and CD97 in Pancreatic Cancer versus Other Malignancies
Cristiana Tănase, Ancuța-Augustina Gheorghișan-Gălățeanu, Ionela Daniela Popescu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5656-5656
Open Access | Times Cited: 26
Activation of pancreatic stellate cells attenuates intracellular Ca2+ signals due to downregulation of TRPA1 and protects against cell death induced by alcohol metabolites
Agnieszka A. Kusiak, Monika A. Jakubowska, Kinga B. Stopa, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 15
Bioinformatics Data Mining Repurposes the JAK2 (Janus Kinase 2) Inhibitor Fedratinib for Treating Pancreatic Ductal Adenocarcinoma by Reversing the KRAS (Kirsten Rat Sarcoma 2 Viral Oncogene Homolog)-Driven Gene Signature
Li-Wei Liu, Yao-Yu Hsieh, Pei‐Ming Yang
Journal of Personalized Medicine (2020) Vol. 10, Iss. 3, pp. 130-130
Open Access | Times Cited: 21
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer
Seval Ay, Muhammed Mustafa Atçı, Rukiye Arıkan, et al.
Journal of Chemotherapy (2022) Vol. 34, Iss. 7, pp. 465-471
Closed Access | Times Cited: 13
Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma
Justyna Budka, Dawid Dębowski, Shaoshan Mai, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 283-283
Open Access | Times Cited: 2
Small molecular inhibitors: Therapeutic strategies for pancreatic cancer
Yuvasri Golivi, Seema Kumari, Batoul Farran, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104053-104053
Closed Access | Times Cited: 2
Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy
María Cecilia Sanmartin, Francisco Raúl Borzone, María Belén Giorello, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 11
Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients
Alice Usai, Gregorio Di Franco, Margherita Piccardi, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4131-4131
Open Access | Times Cited: 15
Oligoadenylate synthetases-like is a prognostic biomarker and therapeutic target in pancreatic ductal adenocarcinoma
Shihong Chen, Zhijian Sun, Weizhu Zhao, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 3, pp. 138-138
Open Access | Times Cited: 9
An anti-bacterial and anti-cancer fibrous membrane with multiple therapeutic effects for prevention of pancreatic cancer recurrence
Qiang Zhang, Yang Luo, Bo Liang, et al.
Biomaterials Advances (2022) Vol. 137, pp. 212831-212831
Open Access | Times Cited: 9
Role of different immune cells and metabolic pathways in modulating the immune response in pancreatic cancer (Review)
Nnenna Elebo, Pascaline Fonteh, J. Omoshoro–Jones, et al.
Molecular Medicine Reports (2020) Vol. 22, Iss. 6, pp. 4981-4991
Open Access | Times Cited: 14
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma
Ahmad H. Ali, Ugo Chianese, Chiara Papulino, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3799-3799
Open Access | Times Cited: 8
Liquid biopsy approach to pancreatic cancer
Sonia Perales, Carolina Torres, Cristina Jiménez‐Luna, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 10, pp. 1263-1287
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top